{"entity":{"type":"insider","cik":"0001780085","url":"/insider/0001780085","json_url":"/insider/0001780085.json","name":"Nash Huw M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":27,"first":"2020-03-04","last":"2024-07-03","span_basis":"filed_date"},"name_variants":[{"name":"Nash Huw M.","source":"filing","n_filings":27,"first_seen":"2020-03-04","last_seen":"2024-07-03"}],"transactions":[{"id":2101614,"accession":"0001415889-24-019169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019169","line_url":"/filing/0001415889-24-019169","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":13.1115468,"price_display":"13.11","price_state":"stated","total_value":32778.867,"total_display":"32,778.87","total_whole":"32,779","shares_owned_after":33.0,"shares_owned_after_display":"33","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-03","scope":"insider","n_lines":2},{"id":2101262,"accession":"0001415889-24-014093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-014093","line_url":"/filing/0001415889-24-014093#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":15.39,"price_display":"15.39","price_state":"stated","total_value":769500.0,"total_display":"769,500.00","total_whole":"769,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":2709883,"accession":"0001415889-24-009993","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-009993","line_url":"/filing/0001415889-24-009993","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61329.0,"shares_display":"61,329","price_per_share":13.227213003636127,"price_display":"13.23","price_state":"stated","total_value":811211.7463,"total_display":"811,211.75","total_whole":"811,212","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":2},{"id":2369394,"accession":"0001415889-24-008686","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-008686","line_url":"/filing/0001415889-24-008686#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4116.0,"shares_display":"4,116","price_per_share":6.0986,"price_display":"6.10","price_state":"stated","total_value":25101.8376,"total_display":"25,101.84","total_whole":"25,102","shares_owned_after":11329.0,"shares_owned_after_display":"11,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":6423049,"accession":"0001209191-22-001849","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-001849","line_url":"/filing/0001209191-22-001849","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":23.07003463157895,"price_display":"23.07","price_state":"stated","total_value":87666.1316,"total_display":"87,666.13","total_whole":"87,666","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider","n_lines":3},{"id":4493156,"accession":"0001209191-21-067950","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-067950","line_url":"/filing/0001209191-21-067950","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":24.44378947368421,"price_display":"24.44","price_state":"stated","total_value":139329.6,"total_display":"139,329.60","total_whole":"139,330","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider","n_lines":2},{"id":4847938,"accession":"0001209191-21-062772","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-062772","line_url":"/filing/0001209191-21-062772#line-5","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":47500.0,"total_display":"47,500.00","total_whole":"47,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-03","scope":"insider"},{"id":4847926,"accession":"0001209191-21-062772","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-062772","line_url":"/filing/0001209191-21-062772","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":23.541180789473685,"price_display":"23.54","price_state":"stated","total_value":89456.487,"total_display":"89,456.49","total_whole":"89,456","shares_owned_after":1610.0,"shares_owned_after_display":"1,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider","n_lines":2},{"id":5384481,"accession":"0001209191-21-059111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059111","line_url":"/filing/0001209191-21-059111#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":24.8256,"price_display":"24.83","price_state":"stated","total_value":141505.92,"total_display":"141,505.92","total_whole":"141,506","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-04","scope":"insider"},{"id":4183174,"accession":"0001209191-21-054552","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054552","line_url":"/filing/0001209191-21-054552#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":26.004,"price_display":"26.00","price_state":"stated","total_value":148222.8,"total_display":"148,222.80","total_whole":"148,223","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-02","scope":"insider"},{"id":5429576,"accession":"0001209191-21-049793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-049793","line_url":"/filing/0001209191-21-049793#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":28.8692,"price_display":"28.87","price_state":"stated","total_value":164554.44,"total_display":"164,554.44","total_whole":"164,554","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":4536911,"accession":"0001209191-21-045097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-045097","line_url":"/filing/0001209191-21-045097#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":33.331,"price_display":"33.33","price_state":"stated","total_value":189986.7,"total_display":"189,986.70","total_whole":"189,987","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider"},{"id":5498021,"accession":"0001209191-21-037839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-037839","line_url":"/filing/0001209191-21-037839#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":575.0,"shares_display":"575","price_per_share":39.4252,"price_display":"39.43","price_state":"stated","total_value":22669.49,"total_display":"22,669.49","total_whole":"22,669","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":4881039,"accession":"0001209191-21-002246","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-002246","line_url":"/filing/0001209191-21-002246#line-6","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32.0,"shares_display":"32","price_per_share":57.1401,"price_display":"57.14","price_state":"stated","total_value":1828.4832,"total_display":"1,828.48","total_whole":"1,828","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-06","scope":"insider"},{"id":4881032,"accession":"0001209191-21-002246","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-002246","line_url":"/filing/0001209191-21-002246","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":58.9749,"price_display":"58.97","price_state":"stated","total_value":336156.93,"total_display":"336,156.93","total_whole":"336,157","shares_owned_after":2032.0,"shares_owned_after_display":"2,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":4},{"id":2446476,"accession":"0001209191-20-064582","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-064582","line_url":"/filing/0001209191-20-064582#line-4","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8015.0,"shares_display":"8,015","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":480900.0,"total_display":"480,900.00","total_whole":"480,900","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-18","scope":"insider"},{"id":2446467,"accession":"0001209191-20-064582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-064582","line_url":"/filing/0001209191-20-064582#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41985.0,"shares_display":"41,985","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":2519100.0,"total_display":"2,519,100.00","total_whole":"2,519,100","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-18","scope":"insider"},{"id":2346380,"accession":"0001209191-20-061591","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-061591","line_url":"/filing/0001209191-20-061591","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":49.838530684210525,"price_display":"49.84","price_state":"stated","total_value":284079.6249,"total_display":"284,079.62","total_whole":"284,080","shares_owned_after":2981.0,"shares_owned_after_display":"2,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider","n_lines":4},{"id":2690559,"accession":"0001209191-20-057717","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-057717","line_url":"/filing/0001209191-20-057717#line-3","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":2250000.0,"total_display":"2,250,000.00","total_whole":"2,250,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-10","scope":"insider"},{"id":2345105,"accession":"0001209191-20-056950","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-056950","line_url":"/filing/0001209191-20-056950","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":37.21226070175439,"price_display":"37.21","price_state":"stated","total_value":212109.886,"total_display":"212,109.89","total_whole":"212,110","shares_owned_after":2536.0,"shares_owned_after_display":"2,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider","n_lines":2},{"id":2912567,"accession":"0001209191-20-053732","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-053732","line_url":"/filing/0001209191-20-053732","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":34.543950877192984,"price_display":"34.54","price_state":"stated","total_value":196900.52,"total_display":"196,900.52","total_whole":"196,901","shares_owned_after":2300.0,"shares_owned_after_display":"2,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider","n_lines":2},{"id":3046792,"accession":"0001209191-20-050031","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-050031","line_url":"/filing/0001209191-20-050031#line-4","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17201.0,"shares_display":"17,201","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":516030.0,"total_display":"516,030.00","total_whole":"516,030","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider"},{"id":3046787,"accession":"0001209191-20-050031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050031","line_url":"/filing/0001209191-20-050031#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30718.0,"shares_display":"30,718","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":921540.0,"total_display":"921,540.00","total_whole":"921,540","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2557740,"accession":"0001209191-20-049551","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-049551","line_url":"/filing/0001209191-20-049551","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":27.739057894736842,"price_display":"27.74","price_state":"stated","total_value":158112.63,"total_display":"158,112.63","total_whole":"158,113","shares_owned_after":700.0,"shares_owned_after_display":"700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider","n_lines":2},{"id":3323551,"accession":"0001209191-20-048841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-048841","line_url":"/filing/0001209191-20-048841#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2081.0,"shares_display":"2,081","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":62430.0,"total_display":"62,430.00","total_whole":"62,430","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-08-31","scope":"insider"},{"id":3011129,"accession":"0001209191-20-044723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-044723","line_url":"/filing/0001209191-20-044723#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":24.7269,"price_display":"24.73","price_state":"stated","total_value":140943.33,"total_display":"140,943.33","total_whole":"140,943","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-04","scope":"insider"},{"id":3199014,"accession":"0001209191-20-042943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042943","line_url":"/filing/0001209191-20-042943#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":25.06,"price_display":"25.06","price_state":"stated","total_value":47614.0,"total_display":"47,614.00","total_whole":"47,614","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-16","filed_date":"2020-07-17","scope":"insider"},{"id":3258443,"accession":"0001209191-20-042004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042004","line_url":"/filing/0001209191-20-042004#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":913.0,"shares_display":"913","price_per_share":22.4062,"price_display":"22.41","price_state":"stated","total_value":20456.8606,"total_display":"20,456.86","total_whole":"20,457","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2437064,"accession":"0001209191-20-040613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-040613","line_url":"/filing/0001209191-20-040613#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":23.1494,"price_display":"23.15","price_state":"stated","total_value":87967.72,"total_display":"87,967.72","total_whole":"87,968","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2646038,"accession":"0001209191-20-034091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-034091","line_url":"/filing/0001209191-20-034091","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2107.0,"shares_display":"2,107","price_per_share":27.177625106786902,"price_display":"27.18","price_state":"stated","total_value":57263.2561,"total_display":"57,263.26","total_whole":"57,263","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-03","scope":"insider","n_lines":2},{"id":2644118,"accession":"0001209191-20-016360","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-016360","line_url":"/filing/0001209191-20-016360","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001780085","owner_name":"Nash Huw M.","owner_display_name":"Nash Huw M.","owner_url":"/insider/0001780085","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49143.0,"shares_display":"49,143","price_per_share":25.894820072034673,"price_display":"25.89","price_state":"stated","total_value":1272549.1428,"total_display":"1,272,549.14","total_whole":"1,272,549","shares_owned_after":15995.0,"shares_owned_after_display":"15,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Officer (Chief Business Officer)","n_filings":27,"first_seen":"2020-03-04","last_seen":"2024-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780085","retrieved_at":"2026-08-23T20:21:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}